High Tech Pharm Co., Ltd. (KOSDAQ:106190)
South Korea · Delayed Price · Currency is KRW 13,310
-440 (-3.20%)
At close: Sep 15, 2025
High Tech Pharm Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Operating Revenue | 74,653 | 77,513 | 76,772 | 102,947 | 73,287 | 74,462 | Upgrade |
Other Revenue | - | - | -0 | - | - | 0 | Upgrade |
| 74,653 | 77,513 | 76,772 | 102,947 | 73,287 | 74,462 | Upgrade | |
Revenue Growth (YoY) | -10.60% | 0.97% | -25.43% | 40.47% | -1.58% | 18.07% | Upgrade |
Cost of Revenue | 58,538 | 58,032 | 63,938 | 95,177 | 70,216 | 73,155 | Upgrade |
Gross Profit | 16,115 | 19,481 | 12,834 | 7,770 | 3,071 | 1,308 | Upgrade |
Selling, General & Admin | 3,691 | 3,790 | 2,601 | 2,705 | 3,310 | 4,551 | Upgrade |
Other Operating Expenses | 58.8 | 59.44 | 61.83 | 47.33 | 115.54 | 30.1 | Upgrade |
Operating Expenses | 3,825 | 3,923 | 2,745 | 2,843 | 3,483 | 4,631 | Upgrade |
Operating Income | 12,290 | 15,558 | 10,089 | 4,927 | -412.02 | -3,324 | Upgrade |
Interest Expense | -523.05 | -787.27 | -896.47 | -463.69 | -252.07 | -327.02 | Upgrade |
Interest & Investment Income | 10.38 | 8 | 4.69 | 4.31 | 84.73 | 96.39 | Upgrade |
Currency Exchange Gain (Loss) | -55.18 | 1,871 | 278.34 | -829.89 | -290.52 | 493.51 | Upgrade |
Other Non Operating Income (Expenses) | 1,185 | 307.37 | 282.41 | 267.28 | 1.82 | 466.46 | Upgrade |
EBT Excluding Unusual Items | 12,907 | 16,957 | 9,758 | 3,905 | -868.07 | -2,595 | Upgrade |
Gain (Loss) on Sale of Investments | 112.66 | 129.57 | 115.56 | 54.65 | - | - | Upgrade |
Gain (Loss) on Sale of Assets | 3 | - | -9.51 | 68.11 | 0.14 | -5 | Upgrade |
Pretax Income | 13,022 | 17,087 | 9,864 | 4,028 | -867.94 | -2,600 | Upgrade |
Income Tax Expense | 2,459 | 3,377 | 1,787 | -1,845 | 357.46 | 552.52 | Upgrade |
Net Income | 10,564 | 13,710 | 8,076 | 5,873 | -1,225 | -3,152 | Upgrade |
Net Income to Common | 10,564 | 13,710 | 8,076 | 5,873 | -1,225 | -3,152 | Upgrade |
Net Income Growth | -21.88% | 69.75% | 37.52% | - | - | - | Upgrade |
Shares Outstanding (Basic) | 11 | 11 | 7 | 11 | 11 | 11 | Upgrade |
Shares Outstanding (Diluted) | 11 | 11 | 7 | 11 | 11 | 11 | Upgrade |
Shares Change (YoY) | 50.28% | 49.99% | -33.33% | - | - | - | Upgrade |
EPS (Basic) | 993.54 | 1289.43 | 1139.33 | 552.32 | -115.24 | -296.44 | Upgrade |
EPS (Diluted) | 991.66 | 1289.43 | 1139.33 | 552.32 | -115.24 | -296.44 | Upgrade |
EPS Growth | -48.02% | 13.17% | 106.28% | - | - | - | Upgrade |
Free Cash Flow | 16,859 | 12,558 | -2,183 | -4,359 | 6,068 | -8,628 | Upgrade |
Free Cash Flow Per Share | 1582.60 | 1181.10 | -307.89 | -409.94 | 570.68 | -811.43 | Upgrade |
Gross Margin | 21.59% | 25.13% | 16.72% | 7.55% | 4.19% | 1.76% | Upgrade |
Operating Margin | 16.46% | 20.07% | 13.14% | 4.79% | -0.56% | -4.46% | Upgrade |
Profit Margin | 14.15% | 17.69% | 10.52% | 5.71% | -1.67% | -4.23% | Upgrade |
Free Cash Flow Margin | 22.58% | 16.20% | -2.84% | -4.23% | 8.28% | -11.59% | Upgrade |
EBITDA | 17,578 | 20,727 | 15,075 | 10,472 | 5,139 | 2,128 | Upgrade |
EBITDA Margin | 23.55% | 26.74% | 19.64% | 10.17% | 7.01% | 2.86% | Upgrade |
D&A For EBITDA | 5,288 | 5,169 | 4,986 | 5,545 | 5,551 | 5,452 | Upgrade |
EBIT | 12,290 | 15,558 | 10,089 | 4,927 | -412.02 | -3,324 | Upgrade |
EBIT Margin | 16.46% | 20.07% | 13.14% | 4.79% | -0.56% | -4.46% | Upgrade |
Effective Tax Rate | 18.88% | 19.76% | 18.12% | - | - | - | Upgrade |
Advertising Expenses | - | 192.85 | 97.61 | 84.51 | 13.86 | 26.59 | Upgrade |
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.